GPCR Latest Press Releases

-- June 5, 2026 --

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity Globe Newswire 4:05 PM

-- May 26, 2026 --

Structure Therapeutics Announces Participation in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- May 7, 2026 --

Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights Globe Newswire 4:05 PM

-- April 27, 2026 --

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions Globe Newswire 4:05 PM

-- April 14, 2026 --

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel Globe Newswire 4:05 PM

-- March 16, 2026 --

Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron Globe Newswire 7:00 AM

-- February 26, 2026 --

Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights Globe Newswire 4:02 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software